Discussion This study demonstrated a significant association between GLP-1RA use and the development of hypersomnolence over both short- and long-term follow-up periods
The coaching, the habit support, and the tools you use every day are what help you hold on to your progress as your treatment evolves
Contact Promega to obtain a license for use of this material with reagents other than a Bio-Glo branded luciferase reagent, including but not limited to: 4.2.1 Bio-Glo, Bio-Glo-NL, Bio-Glo-NB TCK, Bio-Glo-NB VLP, Bio-Glo-NB Lytic 5
Abbreviations T2D: Type 2 diabetes CVD: Cardiovascular disease MASLD: Metabolic dysfunction-associated steatotic liver disease WAT: White adipose tissue IR: Insulin resistance CNS: Central nervous system FFAs: Free fatty acids IRS: Insulin receptor substrates PI3K: AKT-phosphatidylinositol3-kinase PKB: Protein kinase B GLUT4: Glucose transporter 4 MAPK: Ras-mitogen-activated protein kinase BMI: Body mass index VAT: Visceral adipose tissue SAT: Subcutaneous adipose tissue SVF: Stromal vascular fraction ASCs: Adipose stem cells ECM: Extracellular matrix HOMA-IR: Homeostatic Model Assessment for Insulin Resistance IS: Insulin sensitivity LEP-R: leptin receptor GHS-R: growth hormone secretagogue-receptor GLP-1: Glucagon-like peptide-1 GIP: Glucose-dependent insulinotropic polypeptide TSH: Thyrotropin THs: Thyroid hormones FT3: Free triiodothyronine FT4: And free thyroxine HPT: Hypothalamus-pituitary-thyroid axis TRH: Thyrotropin-releasing hormone SHBG: Sex hormone-binding globulin CS: Cushings syndrome 11 HSD: 11-hydroxysteroid-dehydrogenase References Jani M, Jane A, El-Tanani M, Rizzo M
Our data indicate a novel function of metformin as a modulator of incretin-mediated insulin secretion
